← Leaderboards
Iris Y Navarro-Millãn
Weill Medical Coll Of Cornell Univ
$1,027,660
Attributed
$1,027,660
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $171.8K · FY2017–22$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,027,660 · 1
By mechanism
K23$1,027,660 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Martin F Shapiro$11,123,560
- Kerri Aronson$768,476
- Paul Michael Riegelhaupt$2,601,670
- Michael Pesko$5,819,721
- Ethel Cesarman$22,572,616
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignEvidence BaseActive LearningDatabasesDisease RemissionAttitudeAlabamaBaseArthritisCardiovascular DiseasesAchievementAttentionCareerCaregiversCaringAwardCholesterolChronicBeliefClinical TrialsCollaborationsCommunitiesCardiovascular Disorder RiskFocus Groups
Grant awards (7)
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$171,180
K23 · FY2022 · AR · contact PI
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$171,180
K23 · FY2021 · AR · contact PI
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$171,180
K23 · FY2020 · AR · contact PI
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$580
K23 · FY2020 · AR · contact PI
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$171,180
K23 · FY2019 · AR · contact PI
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$171,180
K23 · FY2018 · AR · contact PI
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development$171,180
K23 · FY2017 · AR · contact PI